Podcasts about bcl

John N. Allan, MD and Andrew H. Lipsky, MD discuss the evolution of CLL therapy and the power of doublet and triplet regimens, exploring combinations including BTK inhibitors with BCL-2 inhibitors and anti-CD20 monoclonal antibodies.

Ça y est, la saison EuroLeague est terminée ! Le Fenerbahçe a été sacré champion face à l'AS Monaco. Une finale entre le club turc et la Roca Team qui aura été une véritable surprise à Abu Dhabi. L'occasion pour Romain et Lucas de revenir sur la rencontre, ce qui a marché et raté pour les deux équipes, et pourquoi pas aussi se projeter sur l'avenir, les dynamiques des deux équipes et l'intersaison qui approche... Enjoy-------------------------------------------- ABONNEZ-VOUS

國泰世華 CUBE Podcast 節目「解鎖從容理財」由主持人小詹與證券投資分析師薯哥分享財經情勢與理財小故事的與你一起創造「從容投資、品味理財」的態度生活。立即收聽 ➡️ https://fstry.pse.is/7l4x2c —— 以上為 KKBOX 與 Firstory Podcast 廣告 —— 錄音當下PLG總冠軍賽第六戰落幕，領航猿在背水一戰中成功扳回一城，將系列賽逼進PLG史上首場Game 7！然而，當我們的目光還停留在PLG的激烈對決時，另一邊TPBL的季後賽舞台已悄然搭建完成。這場全新賽事的王者之爭，新聯盟的首個總冠軍究竟會花落誰家？ 本週，小人物上籃誠邀全家海神助教Sean，為大家帶來最專業的TPBL季後挑戰賽解析！Sean將為我們深度剖析戰神與雲豹的攻防特色，兩隊的優勢與短板又會如何影響比賽走向？這次的節目，絕對是所有台籃迷不容錯過的戰術盛宴！ 除了賽事分析，我們還準備了一些「殘酷數據」。一位熱心的小人物提供了今年各隊進場人數的詳細數據，與去年相比，數據的變化讓人驚訝：誰的進場人數暴跌？又是誰逆勢上漲？哪支球隊的公關票派得最凶？誰的票房數據最真實？這些問題，我們將用放大鏡逐一檢視，帶你看清台籃市場的真實面貌。 另外，最近有粉絲留言抱怨我們沒有針對PLG總決賽每場比賽進行分析。在這裡，我們要鄭重澄清：我們有做啦！只要加入我們的小人物上籃會員，就能聽到Roy又哭又笑的情緒起伏、小枚一針見血的評論，以及Kong專業同時一直挖苦Roy的賽事分析。想要掌握台籃季後賽的每場戰況，現在就訂閱小人物上籃會員吧！ 台籃的季後賽熱潮才剛剛開始，無論是PLG的Game 7還是TPBL的挑戰賽，每一場比賽都值得我們全情投入。快到各大podcast平台搜尋小人物上籃，持續鎖定霹靂鍵盤！ 成為

Valencia Basket sigue en pleno proceso de análisis, tratando de tomar la decisión correcta respecto a la competición europea que jugará la próxima temporada. La Cadena SER viene siguiendo el asunto desde hace meses y avisando de la problemática. Para jugar Euroliga hay que acatar normas leoninas. Un canon de dos millones anuales (dinero que los clubes propietarios utilizan para pagar a jugadores con los que ganar a equipos no propietarios como Valencia Basket) y además renunciar al reparto de beneficios. El asunto contiene la paradoja de muchos temas en La Fonteta: se va a construir un pabellón de 300 millones pero en el club dudan a la hora de pagar 6 en tres temporadas. Dicho esto, como cada uno hacer lo que quiere con su dinero, sería lógico que Valencia optara por la BCL. Una competición peor, pero que no exige el pago de ese canon tan alto. Ahora bien, si la elección es finalmente la BCL, hay que reconsiderar el precio de los abonos. No puede pagarse a precio de Filarmónica de Viena una verbena de la Orquesta Expresiones.

Le Final Four c'est cette semaine !L'EuroLeague va rendre son verdict et pour connaître le futur champion d'Europe rien de mieux que de jouer sa fin de saison à... Abu Dhabi.Monaco, l'Olympiacos, le Panathinaïkos et le Fenerbahçe. Voici les prétendants au titre après des semaines de compétition où tous les matchs comptent.Qui prendra la place sur le trône dimanche ?-------------------------------------------- ABONNEZ-VOUS

El UCAM Murcia logró el pasado domingo una victoria fundamental contra el Baxi Manresa para seguir con alguna opción viva de poder entrar en el play off. Es muy complicado porque no depende de sí mismo ya que el D. Gran Canaria ganó al H.Lleida en el partido aplazado el otro día y ha provocado que, debido a los ‘averages', los de Sito Alonso pueden quedarse fuera de la lucha por el título incluso ganando las tres jornadas que quedan. Pero hay que ir a ganarlas porque en juego también está un billete para Europa. En ese sentido, ante el Baxi Manresa, que es un rival directo en la pelea por una plaza para las competiciones continentales, se superó el average. Ganando un partido más que ellos, se les adelantará en la clasificación.Este fin de semana toca ir a Málaga, una pista que trae los mejores recuerdos del año pasado. Enfrente espera un equipazo como es Unicaja, que acaba de ganar la BCL (su cuarto título esta temporada). Hablamos de ello con nuestro protagonista de la semana, Rodions Kurucs. El jugador letón repasa en La Pizarra cómo está siendo la temporada y nos habla de su futuro más inmediato.

Estamos inmersos en las semifinales de cada conferencia de la NBA y nos está dando para mucho análisis. Los Celtics están también contra las cuerdas (1-2 en el momento de grabar el programa) y Denver dando la cara ante OKC. Todo esto, con mucho análisis de baloncesto europeo, los títulos de Unicaja en la BCL y de Valencia Basket en Liga Femenina Endesa. Traemos muchísimo baloncesto en este capítulo, no te lo puedes perder.

(0:25) Φάιναλ Φορ BCL(9:20) Tα καλύτερα NBA Playoffs των τελευταίων χρόνων(15:48) Βοστώνη – Νέα Υόρκη(26:49) Κλίβελαντ – Ιντιάνα(32:41) Μινεσότα – Γκόλντεν Στέιτ(41:42) Οκλαχόμα - Ντένβερ(56:40) Βραβεία ΝΒΑ Hosted on Acast. See acast.com/privacy for more information.

El palmarés del Unicaja de Málaga desde 2023 es inmejorable.2 Copas del Rey, 2 Basketball Champions League, una Supercopa Endesa y una FIBA Intercontinental CupLos de Ibon Navarro sumaron este domingo un título más a sus vitrinas al ganar al Galatasaray en la Final Four de la BCL y se coronan como el segundo equipo capaz de vencer en temporadas consecutivasEn el programa de hoy hablamos del éxito del Unicaja, de cómo ha sido su año en la BCL y lo que les queda por delanteEscucha este programa cada mañana en nuestro canal de YouTube o bien en plataformas de podcastGIGANTES DAILY es un programa de Gigantes Podcast en el que tendrás cada mañana la información que necesitas de NBA, Euroliga, ACB, FIBA, femenino y más.Dale a seguir y cada mañana, de lunes a viernes, tendrás un tema clave que va a marcar ese día en el mundo del baloncesto. Todo ello de la mano de Gigantes del Basket, el único medio profesional en España que lleva desde 1985 centrándose en exclusiva en el baloncesto. Más en Gigantes.com y nuestras redes socialesContacto: redaccion@gigantes.com

Featuring perspectives from Dr Jennifer R Brown and Prof Paolo Ghia, including the following topics: Introduction: The Chronic Lymphocytic Leukemia (CLL) Experience — 2000 to 2025 (0:00) Current Therapy Options with Covalent Bruton Tyrosine Kinase (BTK) Inhibitors (9:42) Role of Venetoclax in the Treatment of CLL (26:52) AMPLIFY Trial and Other Novel BTK Inhibitor and Bcl-2 Inhibitor Combination Strategies (32:29) Noncovalent BTK Inhibitor Pirtobrutinib (46:47) CAR T-Cell Therapy; Novel Agents (56:12) CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Chronic Lymphocytic Leukemia | Faculty Presentation 1: Current Role of Covalent Bruton Tyrosine Kinase Inhibitors and Bcl-2 Inhibitors in Chronic Lymphocytic Leukemia (CLL) — Paolo Ghia, MD, PhD CME information and select publications

In Part 2 of this candid global conversation, Karl Tabbakh returns to The Business of Doing Business to pull back the curtain on the economic uncertainty that's gripping both Canada and the U.S.—and what business leaders need to do about it.Dwayne and Karl dissect the real cost of tariffs, the psychological divide between the “haves” and “have nots,” and what a future recession could mean for Canadian competitiveness. They challenge leaders to rethink productivity, wealth distribution, and their own growth mindset in a time of instability.From political coalitions to personal responsibility, Karl doesn't hold back. If you're in business today, this episode is your compass in the chaos.Timestamps[00:01:00] – The danger of coalitions and the question of democratic representation[00:04:30] – Program creation vs. program funding: Canada's economic blind spot[00:08:30] – Do we have the GDP to fund the lifestyle we promise?[00:10:00] – Why Canada's mindset around growth is dangerously passive[00:13:30] – Who really pays the tariffs—and why they're hidden taxes[00:17:30] – Are tariffs a strategy or political theatre? Dissecting Trump's leverage[00:24:00] – The “Somewheres” vs. “Nowheres”: Stephen Harper's cultural divide explained[00:27:00] – The information echo chamber: Why we don't see disruption coming[00:29:00] – Education, taxation, and why we must fix the divide[00:36:00] – Capitalism's existential threat: What happens when the system loses balance[00:43:30] – CEO pay, productivity, and compensation in a modern economy[00:48:00] – Catching a falling knife: Should you invest in uncertain times?[00:52:00] – When clarity returns, capital will too: Preparing for the rebound[00:57:00] – The world is better than you think—but you have to choose that lens[00:59:00] – Final message: Educate yourself. Lead with purpose. Elevate others.About Karl TabbakhKarl Tabbakh is a lawyer, a business leader and a strategic advisor with over 20 years of international business experience. Karl's expertise is sought after to advise corporations, directors and business executives on a range of strategic issues and transactions both domestically and globally. He is a partner at McCarthy Tétrault LLP with a focus on M&A and private equity and serves on the firm's Senior Leadership Team as National Leader, Markets and International Business. He was appointed by the Government of Canada as Chairman of Invest in Canada, Canada's agency responsible for promoting, attracting and facilitating global foreign direct investments into Canada. He previously served as Chair of the Canadian Chamber of Commerce and was on the Board of directors of the Canada Arab Business Council. Karl is a regular speaker on matters of governance, global investment and mergers and acquisitions. In addition to his career in Canada, Karl spent eight years in the Middle East and four years in London, UK, where he developed a solid international network and gained an understanding of international business and investments. An active community leader, Karl supports and leverages his network to benefit many non-profit and local community service organizations, including as member of the Centraide/United Way campaign. Born in Syria, Karl immigrated with his parents to Canada at age 10. He holds an LLB from Osgoode Hall Law School in Toronto, a BCL from the Université de Montréal and a B.Comm from Université Laval in Québec City. Karl is fluent in French, English, and Arabic.Notable Quotes“Imposing a tariff isn't tax revenue....

El UCAM Murcia sigue sin ganar en casa y ya van casi tres meses en Liga Endesa. El equipo universitario cayó el pasado fin de semana ante el Baskonia (82-91) y suma ya nueve derrotas en competición doméstica ante su afición. Es precisamente en su feudo donde se están escapando los objetivos esta temporada, como la Copa del Rey, el billete para el play off de BCL y veremos si también el play off. En medio de estos resultados, esta semana conocíamos la noticia de que Sito Alonso será el nuevo seleccionador de Letonia a partir de septiembre, después del Eurobasket. Un cargo que no afecta en nada, porque son compatibles, con el UCAM Murcia, donde seguirá la próxima temporada ya que tiene contrato garantizado. Analizamos la actualidad del equipo en la tertulia con Andrés Miso y Laura Fernández. También repasamos los resultados del resto de los equipos de la Región de Murcia: Hozono Global Jairis, el Odilo FC Cartagena y La Salud de Archena.

In today's episode, we had the pleasure of speaking with Nicole Lamanna, MD, about patient selection considerations for the use of pirtobrutinib (Jaypirca) in the management of chronic lymphocytic leukemia (CLL). Dr Lamanna is a hematologic oncologist at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Irving Medical Center in New York, New York. In our exclusive interview, Dr Lamanna discussed how disease progression, treatment intolerance, and prior therapy exposure inform the decision to initiate pirtobrutinib in patients with CLL. She also highlighted important clinical features that guide the use of noncovalent BTK inhibitors—including sequencing strategies following covalent BTK and BCL-2 inhibitors, and emphasized the importance of balancing treatment efficacy with tolerability to optimize long-term disease management in CLL.

In one of the most urgent and eye-opening conversation, Dwayne sits down with Karl Tabbakh—top Canadian business strategist, international dealmaker, and former chair of the Canadian Chamber of Commerce—to unpack the global forces redefining the rules of business, politics, and leadership.Together, they explore what rising geopolitical tension, fractured trade alliances, and shifting world orders mean for entrepreneurs, CEOs, and decision-makers across North America. With experience advising on multi-billion-dollar cross-border transactions and leading strategic investments in Canada and the Middle East, Karl offers a rare lens into how to stay sharp—and sane—in chaotic times.This is part one of a two-part conversation filled with powerful insights on resilience, globalism, and the responsibilities of leadership in the modern era.Timestamps[00:02:45] – Why Karl was the first person Dwayne thought of for this global conversation[00:05:20] – Karl's career snapshot: from billion-dollar deals to chairing Invest in Canada[00:09:45] – A five-year vision framework for career growth and avoiding professional stagnation[00:13:00] – Why global exposure isn't just travel—it's transformational for decision-making[00:17:30] – The danger of only seeing the world through a North American lens[00:21:00] – Are we ignoring the signs of World War III? The breakdown of the post-WWII order[00:25:30] – What the markets are really saying about uncertainty and leadership[00:33:45] – Are nations acting out of fear, or a thirst for certainty?[00:40:00] – Why Canada must rethink its overreliance on one trade partner[00:52:00] – The hard truth about energy, natural gas, and global climate equity[01:03:00] – The upcoming Canadian election: What voters need to be asking[01:11:00] – Vision, will, and resources: Three pillars for Canada's next leader[01:15:00] – Final thoughts: Canada's opportunity to punch above its weight againAbout KarlKarl Tabbakh is a lawyer, a business leader and a strategic advisor with over 20 years of international business experience. Karl's expertise is sought after to advise corporations, directors and business executives on a range of strategic issues and transactions both domestically and globally. He is a partner at McCarthy Tétrault LLP with a focus on M&A and private equity and serves on the firm's Senior Leadership Team as National Leader, Markets and International Business. He was appointed by the Government of Canada as Chairman of Invest in Canada, Canada's agency responsible for promoting, attracting and facilitating global foreign direct investments into Canada. He previously served as Chair of the Canadian Chamber of Commerce and was on the Board of directors of the Canada Arab Business Council. Karl is a regular speaker on matters of governance, global investment and mergers and acquisitions. In addition to his career in Canada, Karl spent eight years in the Middle East and four years in London, UK, where he developed a solid international network and gained an understanding of international business and investments. An active community leader, Karl supports and leverages his network to benefit many non-profit and local community service organizations, including as member of the Centraide/United Way campaign. Born in Syria, Karl immigrated with his parents to Canada at age 10. He holds an LLB from Osgoode Hall Law School in Toronto, a BCL from the Université de Montréal and a B.Comm from Université Laval in Québec City. Karl is fluent in French, English, and Arabic.Notable Quotes“If World War III...

The offseason is nearly over so that means a visit from Kevin Tuve for some rock talk. Daryl Thompson's Blue Crabs tenure is over and so is the Cougars run in the BCL. We fill you up will all these and more on this week's show.

ENTRADAS PARA EL CHACHO Y EL REVERSO:https://www.gigantes.com/tienda/el-reverso-entrevista-sergio-rodriguez-evento/Objetivo cumplido para el Unicaja de Málaga y La Laguna Tenerife en la BCL al meterse en la Final Four tras pasar de cuartos de finalEl Unicaja de Málaga remató su serie de Playoffs contra el Pallacanestro Reggiana al ganar en tierras italianas por 82 a 72. Un 2-0 por la vía rápida para los de Ibon Navarro que les sirve para seguir adelante, evitarse de problemas y, encima, recuperar sensaciones a nivel interno.Más épica fue la victoria de La Laguna Tenerife que tuvo que emplearse a fondo para sellar su eliminatoria, también en Italia, estos contra el Derthona Basket por 77 a 64. Un partido en el que los de Txus Vidorreta tuvieron que sobrevivir en un mal día a nivel ofensivo y donde sacaron su mejor cara en el otro costado. Y como cada jueves os vamos a contar en Gigantes del Basket todo lo sucedido en la BCLEscucha este programa cada mañana en nuestro canal de YouTube o bien en plataformas de podcastGIGANTES DAILY es un programa de Gigantes Podcast en el que tendrás cada mañana la información que necesitas de NBA, Euroliga, ACB, FIBA, femenino y más.Dale a seguir y cada mañana, de lunes a viernes, tendrás un tema clave que va a marcar ese día en el mundo del baloncesto. Todo ello de la mano de Gigantes del Basket, el único medio profesional en España que lleva desde 1985 centrándose en exclusiva en el baloncesto. Más en Gigantes.com y nuestras redes socialesContacto: redaccion@gigantes.com

Recorded- April 7&11, 2025   Uploaded- April 12, 2025 Billy Horton joins the program to talk about last year in Yolo and the future in Marysville. Also a draft recap and a look at the past week in the BCL. And we finish the affiliated to independent review from last week along with a great promo from Grand Junction.

Featuring perspectives from Dr Nicole Lamanna and Dr Kerry Rogers, including the following topics: Introduction (0:00) Current Role of Covalent Bruton Tyrosine Kinase and Bcl-2 Inhibitors in Managing Chronic Lymphocytic Leukemia — Dr Lamanna (10:55) Novel Agents and Combination Strategies — Dr Rogers (31:21) CME information and select publications

Buen inicio de los playoffs de la BCL en cuartos de final para los dos equipos españolesEl Unicaja Málaga ha sumado el primer punto de la eliminatoria de cuartos de final de la Basketball Champions League tras superar al Pallacanestro Reggiana por 105 a 68 en el Martín Carpena. El conjunto de Ibon Navarro dominó la primera mitad y llegó a tener una renta de 23 puntos dentro ya del tercer cuarto cuando los italianos amenazaron con remontar (redujeron 13 puntos la diferencia) y terminaron desinflándose en el último periodo en el que solo anotaron 3 puntos.La Laguna Tenerife pone el 1-0 en la eliminatoria de playoffs, colocándose a una victoria de la Final Four de la BCL, después de derrotar al Derthona Basket por 93-89 en la prórroga. El equipo de Txus Vidorreta podrá sentenciar la eliminatoria ganando en Tortona la próxima semana y manteniendo así su condición de invicto en la competición.

TOYOTA限時優惠！即刻入主 RAV4, ALTIS,COROLLA SPORT,YARiS CROSS 免費升級JBL音響揚聲器，再享最高80萬零利率。打造車內頂級聽覺饗宴，買車就趁現在！ https://fstry.pse.is/7cy4sj —— 以上為 KKBOX 與 Firstory Podcast 廣告 —— 人家罷賽會被沒收比賽，但我們就算天打雷劈也是會繼續錄音。本週台籃有個令人振奮的消息，鋼鐵人終於拿下第二勝啦！擊敗的不是別人，正是聯盟龍頭aka台籃模範生桃園領航猿，到底他們施了什麼魔法，讓領航猿like a baby一樣，敗在他們手上？ 除了PLG，TPBL的卡位戰依舊激烈進行中，本以為雲豹前一週輸給戰神後要下去了，沒想到上週馬上討回來，屋漏偏逢連夜雨，戰神輸完雲豹還要再對上聯盟龍頭國王，毫無懸念吞下二連敗。目前戰神只領先雲豹1場，第三的海神更是和特攻只差0.5場，到底誰能搶到季後賽的最終席次，我們拭目以待。 聊完本週比賽，我們要跟大家隆重宣布，一年一度的台籃非官方獎項正式開跑啦，不管是哪個聯盟，哪支球隊，都都有參賽的資格，在開始投票前，我們預先討論了年度洋將和自創獎項：最佳副手獎，還沒想到投誰嗎？不妨收聽我們的節目，看看誰才是你心中最佳人選吧~ 成為

La saison régulière EuroLeague touche bientôt à sa fin, et pour une fois, le suspense est terminé avant la fin du calendrier : les 10 participants pour la postseason (Play-in et Playoffs) sont désormais connus. Cependant, tout est encore possible sur la journée 34, de la 3ème à la 10ème place, rien n'est assuré. C'est aussi le moment de se questionner sur l'avenir des équipes qui ont manqué le coche (Partizan Belgrade, Olimpia Milano, Zalgiris Kaunas). Et enfin, Romain et Lucas élisent les meilleurs duos, tous postes confondus de l'EuroLeague ! Enjoy

El UCAM Murcia está viviendo los días más complicados de la temporada. Tras su eliminación de BCL, también perdió su partido de Liga Endesa ante el Morabanc Andorra en el Palacio. Analizamos la situación del equipo en la tertulia con Emilio Sánchez-Bolea, Laura Fernández y Andrés Miso. Con el periodista especializado Chema de Lucas conocemos la previa de la jornada liguera y los últimos movimientos del mercado

El Unicaja ha ganado todos los títulos en juego en lo que va de temporada. Los malagueños han sido una apisonadora en todos los momentos clave del curso, pero en las últimas semanas han dado ciertos síntomas de agotamiento¿Hay razones para preocuparse? ¿Por qué hay que mirar al rendimiento como visitantes?En este episodio 200 de Gigantes Daily ponemos la mirada en el Unicaja de Málaga, en cómo les ha ido después de proclamarse campeones de Copa del Rey y qué panorama tienen por delante en términos de calendario y rivalesEscucha este programa cada mañana en nuestro canal de YouTube o bien en plataformas de podcastGIGANTES DAILY es un programa de Gigantes Podcast en el que tendrás cada mañana la información que necesitas de NBA, Euroliga, ACB, FIBA, femenino y más.Dale a seguir y cada mañana, de lunes a viernes, tendrás un tema clave que va a marcar ese día en el mundo del baloncesto. Todo ello de la mano de Gigantes del Basket, el único medio profesional en España que lleva desde 1985 centrándose en exclusiva en el baloncesto. Más en Gigantes.com y nuestras redes socialesContacto: redaccion@gigantes.com

Se acabó la ronda de los 16 mejores de la BCL, con alegrías y despedidas para muchos equipos. El Unicaja sigue adelante, cerrando con triunfo esta fase, al igual que La Laguna Tenerife, que sigue invicto a costa del BAXI Manresa y el UCAM Murcia perdió y queda eliminadoAsí que, de la mano de la FIBA os vamos a contar cómo ha ido la jornada de la BCL con todo lo ocurrido en los partidos y especial foco en los equipos españolesMientras, en el resto de la jornada pasó lo siguiente:El Galatasaray superó sin problemas al Manisa por 104 a 81El Reggio Emilia venció por 77 a 70 al Aliaga PetkimsporEl Derthona selló su pase a la siguiente ronda ganando al Wurzburg por 80 a 74El AEK sufrió para imponerse en casa del Promitheas por 60 a 56Y finalmente el Nanterre ganó para pasar a cuartos, superando al Falco Vulcano por 95 a 89

Le dernier carré de l'Eurocup est connu : Valence, Tel Aviv, Bahcesehir et Gran Canaria ! Pleins de français à suivre et un besoin pour Lucas et Romain de faire le point sur les 1/4 et de se plonger sur la dernière partie de la compétition. Petite gourmandise, on parle même MVP et équipe type de la saison

El Hozono Global Jairis debutaba en la Copa de la Reina con ambición y sin miedo. Así protagonizaron la gran sorpresa eliminando con autoridad al claro favorito al título y uno de los mejores equipos del continente, el Valencia Basket (53-70). En semifinales se medirán al Spar Girona.Por su parte, el UCAM Murcia ha sumado dos derrotas consecutivas, contra el Basquet Girona y contra Nanterre, en BCL.

La Laguna Tenerife se mantiene como único invicto de la competición después de ganar al Aliaga Petkimspor en Turquía por 80-85. Los aurinegros, ya clasificados para los playoffs de la BCL y con la 1ª plaza de grupo asegurada, fueron liderados por Kostas Kostadinov (22 puntos, 10 de 13 en tiros) en la ausencia de Marcelinho Huertas y Fran Guerra.El UCAM Murcia, sin embargo, cayó ante el Nanterre 92 en Francia (76-71) y se jugará el pase a los playoffs en la última jornada. El equipo de Sito Alonso pudo defender su average y ganando al Nymburk en la última jornada logrará el pase.El Unicaja ganó al Manisa logrando la clasificación para los playoffs de la BCL (97-103) y, aprovechando la victoria del Galatasaray ante el Rytas Vilnius, aseguró la primera plaza del grupo. Los malagueños afrontarán la última jornada de la Ronda de 16 con la tranquilidad de haber hecho los deberes gracias a la exhibición de Kam Taylor, que lideró la victoria con 33 puntos (11 de 15 en tiros), 5 rebotes y 5 asistencias.El BAXI Manresa, por su parte, estaba obligado a ganar para seguir con vida en la BCL. El equipo catalán se impuso al Reggio Emilia por 96-90 con un gran Derrick Alston Jr. El estadounidense, autor de 14 puntos en el 2º cuarto, lideró la victoria manresana con 29 puntos y 4 asistencias, que harán que su equipo se juegue el pase en la última jornada.

Featuring an interview with Ms Robin Klebig, including the following topics: Overview of the natural history and treatment landscapes of lymphoma subtypes (0:00) Structure and mechanisms of action of bispecific antibodies (23:41) Similarities and differences among the various approved and investigational CD20 x CD3 bispecific antibodies for non-Hodgkin lymphoma (28:14) Case: A man in his early 50s with multiagent/multiregimen-refractory follicular lymphoma who experienced disease progression with chimeric antigen receptor T-cell therapy now receives mosunetuzumab (39:14) Case: A woman in her mid 60s with relapsed/refractory (R/R) diffuse large B-cell lymphoma receives glofitamab (49:08) Case: A man in his mid 60s with R/R high-grade B-cell lymphoma with MYC and Bcl-2 rearrangements receives epcoritamab (52:57) Case: A man in his early 60s with composite lymphoma receives epcoritamab (56:55) NCPD information and select publications

Nouvelle hebdo en flash autour de l'actualité de l'Euroleague et du round 29 ! Au menu : Retrouvez bien sûr les dernières news de la semaine ! Dans le CQARDLS, l'Olympiacos domine le derby grec, l'ancien parisien Francisco tape son ancien club. Une rengaine aussi entendue du côté de la Catalogne avec Punter face au Partizan !-------------------------------------------- ABONNEZ-VOUS

La Liga Endesa entra en el tramo decisivo. Quedan 12 jornadas para terminar el campeonato y el UCAM Murcia apura sus opciones de poder disputar el play off por el título. Para lograrlo, no puede dejarse muchos partidos por el camino. Tras perder en la pista del Real Madrid, le toca recibir al Basquet Girona en un partido en el que Sito Alonso tendrá a todos los jugadores disponibles. Lo hará después de vencer el miércoles al Falco en la BCL y de seguir aspirando a ser primeros de grupo. Analizaremos en la tertulia con Emilio Sánchez-Bolea (La Verdad), Andrés Miso y Laura Fernández la actualidad del conjunto universitario. De la mano del periodista especializado Chema de Lucas haremos una previa a la próxima jornada.En la Liga Femenina Endesa el Hozono Global Jairis fue partícipe en el Movistar Arena del récord de asistencia en un partido de la máxima categoría del baloncesto femenino español, el pasado domingo. En lo deportivo, cayó 66-57 ante el Movistar Estudiantes y este fin de semana recibe al Club Joventut de Badalona en el último encuentro antes de la Copa de la Reina.

Una semana más te traemos el resumen de la semana de la BCL para La Laguna Tenerife, Unicaja de Málaga, BAXI Manresa y UCAM MurciaLa Laguna Tenerife sigue invicto en la BCL después de remontar 16 puntos de desventaja y vencer al Reggio Emilia por 74-84. David Kramer brilló en la 100ª victoria de Txus Vidorreta en la competición con una exhibición en el tiro. El escolta alemán anotó 7 de sus 9 intentos en el triple para finalizar el partido con 25 puntos. Le siguió Marcelinho Huertas, con 22 tantos y 7 asistencias en el triunfo en Italia.También venció el UCAM Murcia, que se acerca a los playoffs de la BCL y se mantiene colíder de grupo empatado con el Nymburk con un balance de 3-1. El equipo de Sito Alonso derrotó al Falco-Vulcano Szombathely húngaro con más comodidad que en el partido de ida (85-63) liderados por los 20 puntos de Dylan Ennis.El Unicaja sufrió este martes, pero derrotó al Galatasaray por 97-91 tras su derrota sobre la bocina de la pasada semana en Estambul. Los malagueños remontaron 13 puntos de desventaja y se pusieron por delante en el marcador en los últimos minutos. Tyson Carter y Kendrick Perry fueron los máximos anotadores con 16 puntos cada uno. Con el average a favor y una victoria de ventaja sobre el equipo turco, se acercan a los playoffs de la competición.Antes, el BAXI Manresa complicó su presencia en las eliminatorias de la BCL tras caer en su visita a Turquía ante el Aliaga Petkimspor (89-86). Un mal segundo cuarto, que perdieron por 33-11, pasó factura al equipo de Diego Ocampo, que intentó remontar pero se quedó corto. Dani Pérez intentó forzar la prórroga con un lanzamiento desde el medio campo, pero su tiro no entró. Cameron Hunt realizó un gran partido con 23 puntos (5/6 en triples) y 3 asistencias, pero no fue suficiente.

This is Episode 13 of Season 2 of The RUN TMC Podcast Dave and Duffy sit down with San Marin girls coach Tony Butler to unravel the 2025 changes in the NCS selection and seeding process and discuss his coaching journey and philosophy.  Tony shares insights into building a strong team culture, his favorite drills, and adjustments in coaching strategy based on team and player dynamics. Dave and Duffy also serve up a small helping of local Marin basketball news and notes and provide an up to the hour update on the MCAL and BCL playoff pictures. Don't miss it, or you'll miss out. This interview occurred on February 2nd, 2025 Our next episode will air on or around February 12th Show Notes: Musical intro credit to Stroke 9//Logo credit to Katie Levine Content and opinions are those of Dave, Duffy and their guests and not of affiliated organizations or sponsors. email us at: theruntmcpodcast@gmail.com check out our website at: theruntmcpodcast.com Thank you to our sponsors: West End Nursery and Batiste Rhum and San Domenico Nike Summer Basketball Camps and The Hub in San Anselmo  

CME credits: 0.50 Valid until: 23-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/clinical-trial-evidence-that-drives-current-guidelines-for-patients-with-cllsll-and-mcl-receiving-third-line-therapies/32285/ This enduring activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN®), focuses on translating oncology clinical practice guidelines into practical strategies for treating CLL/SLL and MCL. Participants will learn how to integrate clinical trial data into guideline-concordant treatment plans for patients that have progressed following a covalent BTK inhibitor. The program highlights the importance of evidence-based approaches and the use of noncovalent BTK inhibitors for relapsed/refractory CLL/SLL and MCL. Attendees will also explore emerging data that could influence future treatment guidelines, and a case example of a patient with CLL/SLL relapsing after 2 prior lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor.

CME credits: 0.50 Valid until: 23-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/guideline-recommended-treatment-options-for-patients-with-cllsll-and-mcl-that-have-progressed-following-a-covalent-btk-inhibitor/32284/ This enduring activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN®), focuses on translating oncology clinical practice guidelines into practical strategies for treating CLL/SLL and MCL. Participants will learn how to integrate clinical trial data into guideline-concordant treatment plans for patients that have progressed following a covalent BTK inhibitor. The program highlights the importance of evidence-based approaches and the use of noncovalent BTK inhibitors for relapsed/refractory CLL/SLL and MCL. Attendees will also explore emerging data that could influence future treatment guidelines, and a case example of a patient with CLL/SLL relapsing after 2 prior lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor.

CME credits: 0.50 Valid until: 23-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/incorporating-guideline-concordant-care-for-patients-with-cllsll-relapsing-after-2-prior-lines-of-therapy/32286/ This enduring activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN®), focuses on translating oncology clinical practice guidelines into practical strategies for treating CLL/SLL and MCL. Participants will learn how to integrate clinical trial data into guideline-concordant treatment plans for patients that have progressed following a covalent BTK inhibitor. The program highlights the importance of evidence-based approaches and the use of noncovalent BTK inhibitors for relapsed/refractory CLL/SLL and MCL. Attendees will also explore emerging data that could influence future treatment guidelines, and a case example of a patient with CLL/SLL relapsing after 2 prior lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor.

CME credits: 0.50 Valid until: 23-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/emerging-data-with-potentially-guideline-changing-implications-in-cllsll-and-mcl/32287/ This enduring activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN®), focuses on translating oncology clinical practice guidelines into practical strategies for treating CLL/SLL and MCL. Participants will learn how to integrate clinical trial data into guideline-concordant treatment plans for patients that have progressed following a covalent BTK inhibitor. The program highlights the importance of evidence-based approaches and the use of noncovalent BTK inhibitors for relapsed/refractory CLL/SLL and MCL. Attendees will also explore emerging data that could influence future treatment guidelines, and a case example of a patient with CLL/SLL relapsing after 2 prior lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor.

The Sports Rabbi Josh Halickman and Roy Jankelowitz from Israel Sportlooked back at all the State Cup action from Maccabi Tel Aviv getting knocked out as well as the domestic league play as well. We the spoke about the latest in Israeli basketball news from the BCL to the EuroCup and Euroleague.Make sure to subscribe to The Sports Rabbi Show on iTunes, Spotify or Google Podcasts.Also download our fabulous new App available for both Android and iPhone!Click here for the iPhone AppClick here for the Android App

Welcome to the Oncology Brothers podcast! In this episode, hosts Rahul and Rohit Gosain are joined by Dr. John Allan from New York Presbyterian Hospital to discuss the latest highlights from ASH 2024, focusing on Chronic Lymphocytic Leukemia (CLL). We dived into three key studies: 1.⁠ ⁠SEQUOIA Update: Discover how this study led to the approval of Zanubrutinib in the frontline setting and its impressive progression-free survival rates compared to traditional chemotherapy. 2.⁠ ⁠AMPLIFY Study: Learn about the exciting combination of Acalabrutinib with Venetoclax and Obinutuzumab, and how it may pave the way for the first oral doublet/triplet combination approval in the U.S. 3.⁠ ⁠Ongoing Trials: We touch on the CELESTIAL TN-CLL trial and the promising combination of Zanubrutinib with Sonrotoclax, a new BCL-2 inhibitor. Additionally, we discuss the evolving role of CAR-T therapy in CLL, especially for patients who have progressed through multiple lines of treatment. Join us for an insightful discussion on the future of CLL treatment options, the importance of balancing efficacy and side effects, and the exciting developments in the field. Don't forget to check out our other ASH and SABCS 2024 discussions! Subscribe to stay updated on the latest in oncology research and treatments! Website: http://www.oncbrothers.com/ X/Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

In this week's episode, we'll be comparing BTK inhibitors in relapsed/refractory CLL. Then, we'll hear how researchers in the UK unraveled the genetic background of the AnWj blood group.  Finally we'll learn about the role of BCL-2 and BAFF in CLL cell survival following venetoclax therapy. Featured Articles:Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotypeSustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINEVenetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia

Featuring perspectives from Dr Farrukh T Awan, Dr Bita Fakhri, Dr Kerry A Rogers and Dr William G Wierda, moderated by Dr Jeff Sharman, including the following topics: Introduction (0:00) Optimizing First-Line Therapy for Chronic Lymphocytic Leukemia (CLL) — Jeff Sharman, MD (1:44) Emerging Role of Bruton Tyrosine Kinase (BTK) Inhibitors in Combination with Bcl-2 Inhibitors — Kerry A Rogers, MD (25:43) Optimal Management of Adverse Events with BTK and Bcl-2 Inhibitors; Considerations for Special Patient Populations — Farrukh T Awan, MD (49:20) Integration of Noncovalent BTK Inhibitors into the Management of Relapsed/Refractory CLL — Bita Fakhri, MD, MPH (1:11:52) Chimeric Antigen Receptor T-Cell Therapy and Other Novel Strategies for CLL — William G Wierda, MD, PhD (1:35:06) CME information and select publications

Recorded- December 13, 2024   Uploaded- December 14, 2024   In a slower week, we focus on the smaller things like Washington's new field, a return of the BCL, and a look at Diamond Baseball Holdings.

I'm so excited to have Dr. Bruce Lessey of ReceptivaDX join me on the podcast. Dr. Lessey has dedicated his research life to studying the lining of the uterus and more specifically, how to help embryos stick better. His research led to the discovery of the role of BCL-6 in the lining of the uterus as a diagnostic test patients can have done by their doctors to guide them toward the best protocol for transfer success. The test isn't for women just going through IVF either. This test can also be done to help women get an endometriosis diagnosis without going through a laparoscopy surgery. ⁠ ⠀ ⠀⁠ In addition to being a Fertility Doctor at The Fertility Center of the Carolinas, in Greenville SC, Dr. Lessey is also the scientific advisor for Cicero DX. His work on identifying BLC6 became the key component of the Receptivadx test. ⁠ ⠀ ⠀⁠ I'm delighted to have him on the show! Many IVF patients have benefited greatly from the Receptivadx test, and I'm looking forward to asking him a lot of questions about his work. ⁠ Read the full show notes and transcript on Dr. Aimee's website Find out more about ReceptivaDX here: https://receptivadx.com/ Would you like to learn more about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, December 16th, 2024 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Subscribe to my YouTube channel for more fertility tips! Subscribe to the newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.

Recorded November 18, 2024. Trinity Long Room Hub Visiting Research Fellow Dr Shreya Atrey (Bonavero Institute of Human Rights, Oxford) in conversation with Prof Mark Bell (School of Law, TCD). Shreya Atrey is an Associate Professor in International Human Rights Law at the Faculty of Law, University of Oxford, and is based at the Bonavero Institute of Human Rights. She is an associate member of the Oxford Human Rights Hub, an Official Fellow and Racial Justice and Equality Fellow at Kellogg College, and a Senior Teaching Fellow at New College. Shreya is the Editor of the Human Rights Law Review (OUP). Previously, she was based at the University of Bristol Law School and has been a Max Weber Fellow at the European University Institute, Florence, and a Hauser Postdoctoral Global Fellow at the NYU School of Law, New York. She completed BCL with distinction and DPhil in Law on the Rhodes Scholarship from Magdalen College, University of Oxford. Shreya works on equality and human rights issues in comparative and international law. Her first monograph, Intersectional Discrimination (OUP 2019) won the runner-up Peter Birks Book Prize in 2020. Learn more at https://www.tcd.ie/trinitylongroomhub/

In Episode 2 of Season 2 of the Run TMC podcast, join hosts Duffy Ballard and Dave Levine on another deep dive into local basketball. In this episode, Dave sits down with Carly Amborn, an extraordinary basketball talent hailing from Marin County. Known affectionately as "The Prodigy" (or "Prod") by her peers, Carly shares her journey from playing CYO basketball against the boys, to competing in the MCAL and BCL with Archie Williams and San Domenico High Schools, to thriving in club basketball on the national stage with the elite Jason Kidd Select program, to securing a scholarship to play basketball at Stanford University in 2025. The interview with Carly was conducted on August 16th, 2024, after she made substantially more shots than Dave did in a shooting workout. Our next episode will drop on October 30th Show Notes: Musical intro credit to Stroke 9//Logo credit to Katie Levine Content and opinions are those of Dave, Duffy and their guests and not of affiliated organizations or sponsors. email us at: theruntmcpodcast@gmail.com check out our website at: theruntmcpodcast.com Thank you to our sponsors: Batiste Rhum and San Domenico Nike Summer Basketball Camps and The Hub in San Anselmo AI Summary Carly recounts her experiences growing up with a professional athlete as a parent and how it shaped her passion for basketball. Despite having multiple Division I offers, she explains why Stanford was always her dream school and delves into the recruiting process, including the differences between official and unofficial visits. Listeners will gain insight into Carly's club basketball experiences, where she played on the national stage for Jason Kidd Select, and how she handled the pressures of performing in front of top college coaches. Carly also discusses her participation in the U.S. National team tryouts and the invaluable lessons she learned from those high-stakes environments. Whether you're a young athlete aspiring to reach the next level or a fan of women's basketball, Carly's story of determination, resilience, and passion will inspire and motivate. Don't miss this captivating episode as we explore the making of a prodigy on and off the court.

In this week's episode I'm sharing with you 2 studies that came across my desk recently showcasing the importance of ruling out endometriosis if you've been told you have unexplained infertility. We go through this process with many of our Fertility Confidence Method clients, and advocating for testing when it comes to endometriosis has always been incredibly challenging. Today I'm sharing with you why this is important for those of you who have been struggling with unexplained infertility, recurrent implantation failure, or recurrent miscarriage and other ways we can potentially get answers when it comes to endometriosis that doesn't involve exploratory surgery.   Topics Covered: Statistical rate of endometriosis in unexplained infertility Gold standard endometriosis diagnosis BCL-6 use in endometriosis diagnosis for unexplained infertility   Study One: https://pubmed.ncbi.nlm.nih.gov/38943813/ Study Two: https://pubmed.ncbi.nlm.nih.gov/35642436/   Grab 20% off your first order of Needed supplements over at thisisneeded.com using the code DRKELSEY Fertility Confidence Bootcamp kicked off on Oct 7th, and there's still time to join us! Come build out your fertility care plan with me this week by registering at ttc.kelseyduncan.com/bootcamp

In today's episode, we're exploring a transformative concept championed by Keith McCurdy: the shift from raising children as consumers to nurturing them as contributors. In a world that often prioritizes “me first,” this mindset asks a different question: “How can I help?”But how does this philosophy play out in real life? The Classical School of Wichita put it to the test, and the results are inspiring. Their school culture has been transformed as students have taken ownership—not just of their learning, but of their entire community. From leading projects to supporting each other, these students have become active contributors.Join us as we delve into their journey with Classical School of Wichita teachers Grant Bickell and Evan Adams who share practical ways you can encourage your own children to become contributors, both at home and in school. This is an episode you won't want to miss—right here on BCL!Special Thanks to our sponsors!ZipCastWilson Hill AcademyAmericas Christian Credit UnionClassic Learning TestGordon CollegeClassical Academic PressLife Architects Coaching Stay tuned for more enlightening discussions on classical Christian education, and join us next time on BaseCamp Live! Remember to subscribe, leave us a review, and reach out to us at info@basecamplive.comDon't forget to visit basecamplive.com for more info and past episodes.

Have you ever noticed how asking the right question can spark incredible growth, deeper understanding, and engaging conversations? That's the dream of every teacher and parent, but it's not always easy! Jesus certainly knew the power of a well-placed question, often using them to challenge his listeners, provoke thought, and reveal deeper truths.Imagine using the same strategy to awaken meaningful conversations with your children, even in the back of the minivan on the ride home from school. So, what makes for a good and effective question, whether in the classroom or at a family meal?Our guest, Sarah Abbott, shares with us the Five Common Topics—a proven method to supercharge conversations both in the classroom and at home. Stay tuned for this episode of BCL as we learn how to ask the kind of questions that inspire and connect!We are thrilled to share the rollout of our new media platform, ZipCast, bridging communication between schools and parents and encouraging them on the go with what they need to know. Learn more about ZipCast at https://www.zipcast.media or reach out to us at hello@zipcast.media!Special thanks to this week's incredible sponsors:Americas Christian Credit UnionClassic Learning TestGutenberg CollegeClassical Academic PressLife Architects Coaching Stay tuned for more enlightening discussions on classical Christian education, and join us next time on BaseCamp Live! Remember to subscribe, leave us a review, and reach out to us at info@basecamplive.comDon't forget to visit basecamplive.com for more info and past episodes.

Imagine it's 1927, and you're flipping through a National Geographic magazine. On the back cover, a full-page ad invites you to join the Book of the Month Club, promising to send you a different great book each month. The tagline reads, “Relive the books that charmed you in your youth.”Fast forward 100 years, and what charmed most of us in our youth likely wasn't one of those great books that shaped Western thought and culture. Today, many Americans don't read regularly, and even fewer delve into the timeless classics that answer so many of life's basic questions.But it's never too late to start. Reading isn't just critical for our students; it's equally important for us as adults. So why not rediscover the joy of reading? Join us for this episode of BCL, where we explore the timeless value of great literature and how it can still enrich our lives today with special guest Cherie Harder, who has helped facilitate this for so many people.We are thrilled to share the rollout of our new media platform, ZipCast, bridging communication between schools and parents and encouraging them on the go with what they need to know. Learn more about ZipCast at https://www.zipcast.media or reach out to us at hello@zipcast.media!Special thanks to this week's incredible sponsors:Americas Christian Credit UnionClassic Learning TestGutenberg CollegeClassical Academic PressLife Architects Coaching Stay tuned for more enlightening discussions on classical Christian education, and join us next time on BaseCamp Live! Remember to subscribe, leave us a review, and reach out to us at info@basecamplive.comDon't forget to visit basecamplive.com for more info and past episodes.